Your session is about to expire
← Back to Search
Behavioural Intervention
Digital Tai Chi Therapy for Long COVID (TaiChi-DTx Trial)
N/A
Waitlist Available
Led By Tim Shi, MD, PhD
Research Sponsored by Tim Shi
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-6 weeks
Awards & highlights
TaiChi-DTx Trial Summary
This trial will compare a digital tai chi intervention with usual care to see if it helps people with long-term COVID-19 symptoms.
Who is the study for?
This trial is for individuals who had a confirmed COVID-19 infection via PCR test in the past 3 to 6 months and are experiencing moderate ongoing symptoms (Grade 2 or 3 on the PCFS scale). It's not suitable for those with severe illnesses requiring ICU admission, psychiatric diseases, or new/exacerbated co-morbidities during COVID.Check my eligibility
What is being tested?
The study tests a Tai Chi Digital Therapy Software Application designed to alleviate long-term COVID-19 symptoms like breathlessness, fatigue, cognitive issues, and muscle pain. Participants will be randomly assigned to either use this digital therapy or be in a control group.See study design
What are the potential side effects?
Since this intervention involves non-invasive digital therapy based on Tai Chi principles, significant side effects are not anticipated. However, some participants may experience discomfort due to physical activity involved.
TaiChi-DTx Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4-6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Physical Activity ability measured by 6-minute walking distance measurement (6MWT)
Cognitive impairment improvement measured by the well-validated neuropsychological measurement tests
Overall respiratory relief measured by the Post-COVID-19 Functional Status (PCFS) Scale
Secondary outcome measures
Change in number of hours/days absent from work related to Long COVID symptoms survey by web-based questionnaires (time frame 6 months after SARS-CoV-2 infection)
TaiChi-DTx Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: The Multi-domain Tai Chi Digital Therapy GroupActive Control1 Intervention
participants will be provided via a tablet or smart phone the traditional Tai Chi exercise with background music and respiratory control exercise with 18 BPM metronome, and 40 Hz sound stimulation for 4-week therapeutic session.
Group II: The regular Tai Chi Exercise GroupPlacebo Group1 Intervention
participants will be provided by the same way to deliver traditional Tai Chi exercise with plain music background, but without respiratory control exercise or 40 Hz sound stimulation. All participants will receive any other routine care or treatment as usual (TAU).
Find a Location
Who is running the clinical trial?
Tim ShiLead Sponsor
1 Previous Clinical Trials
5,000 Total Patients Enrolled
Tim Shi, MD, PhDPrincipal InvestigatorGlobalMD Organization
1 Previous Clinical Trials
5,000 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You were diagnosed with COVID-19 using a PCR test in the last 3 to 6 months.You are currently in the Intensive Care Unit because of a severe illness like COVID-19.You have mental health conditions and other physical health issues.You have developed COVID-19 or other health problems around the same time as the start of the study.You must have moderate to severe symptoms according to the Post-COVID-19 Functional Status (PCFS) Scale.
Research Study Groups:
This trial has the following groups:- Group 1: The Multi-domain Tai Chi Digital Therapy Group
- Group 2: The regular Tai Chi Exercise Group
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Shortness of Breath Patient Testimony for trial: Trial Name: NCT05419219 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the requisite qualifications for participating in this trial?
"This clinical trial is accepting 200 myalgia sufferers aged 18-75. To qualify, the patient must present a PCR positive SARS-CoV2 diagnosis from the last 3 to 6 months and be rated Grade 2 or higher on the Post-COVID-19 Functional Status (PCFS) Scale."
Answered by AI
Is the recruitment process for participants still ongoing?
"Clinicaltrials.gov reports that this medical trial is not currently enrolling patients, as the most recent update was on June 21st 2022. Nevertheless, there are 414 alternative clinical trials which presently seek volunteers for their studies."
Answered by AI
Could individuals over the age of eighty-five be admitted to this clinical trial?
"This medical study seeks out participants who have not yet reached the age of 75 and are legally capable of providing informed consent."
Answered by AI
Who else is applying?
What site did they apply to?
Tim Shi
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
3+
What state do they live in?
Vermont
Alabama
Texas
Why did patients apply to this trial?
I'm desperate and I lived in Vietnam and would see people practicing it all the time outside.
PatientReceived 1 prior treatment
I am not sure about what level of functional impairment I have. I am diagnosed Long Covid and I have gone from rowing 20-30 minutes daily last summer, to struggling to take socks off at night (bedtime is now 6-7 pm, what a lame existance). I would prefer not to travel, but am open.
PatientReceived 1 prior treatment
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger